Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia.
Saved in:
| Title: | Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia. |
|---|---|
| Authors: | Salles, Gilles1 (AUTHOR) gilles.salles@chu-lyon.fr, Bachy, Emmanuel1 (AUTHOR), Smolej, Lukas2 (AUTHOR), Simkovic, Martin2 (AUTHOR), Baseggio, Lucile1 (AUTHOR), Panovska, Anna3 (AUTHOR), Besson, Hervé4 (AUTHOR), Healy, Nollaig5 (AUTHOR), Garside, Jamie6 (AUTHOR), Iraqi, Wafae7 (AUTHOR), Diels, Joris8 (AUTHOR), Pick-Lauer, Corinna9 (AUTHOR), Spacek, Martin10 (AUTHOR), Urbanova, Renata11 (AUTHOR), Lysak, Daniel12 (AUTHOR), Hermans, Ruben13 (AUTHOR), Lundbom, Jessica13 (AUTHOR), Callet-Bauchu, Evelyne1 (AUTHOR), Doubek, Michael3,14 (AUTHOR) |
| Source: | Annals of Hematology. Dec2019, Vol. 98 Issue 12, p2749-2760. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 09395555 |
|---|---|
| DOI: | 10.1007/s00277-019-03830-8 |
